Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients

P. Morales, M. Santos, A. Gil, A. Navarro, M. Gobernado (Valencia, Spain)

Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Session: Lung and bone marrow transplantation: miscellaneous
Session type: E-Communication Session
Number: 1632
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Abstract

Mycobacterium abscessus is an ubiquitous, rapidly growing mycobacterium. It is a potential pathogen, especially for immunosuppressed patients (ISP). OBJECTIVE: To present the experience of a tertiary hospital, in the systematic detection of this microorganism, focusing mainly on respiratory infections in ISP. METHODS: Period analyzed: January 1997-December 2006. Data of culture and in vitro susceptibility testing of samples were obtained from the Microbiology Department database. Criteria for the classification of the isolates: a) causing disease (D): direct visualization, different methods of culture, abundant growth, repeated samples and medical history compatible with disease; b) contaminants (C): not direct visualization, delayed growth, unique colony or method; c) colonization (CL): undetermined criteria. RESULTS: Isolation of M. abscessus in 45 patients, 69% in the last 5 years: 20 D: 4 children and 16 adults: 4 (20%) disseminated: (1 astrocitoma, 1 lung transplant (LT)+ cystic fibrosis (CF), 1 sarcoma and 1 osteomyelitis); 16 (80%) localized: 10 respiratory (2 AIDS, 3 CF, 1 LT+CF, 1 LT+COPD, 1 asthma and 2 lung cancer) and 3 catheter-related; 12 C (11 respiratory; 1 urine); 13 CL, all respiratory: 3 (LT). Clinical evolution with treatment has been favourable in all cases. CONCLUSION: 1) M. abscessus isolation has increased in the last five years.2) The cause might be due to the increased number of immunosuppressed patients and/or pulmonary chronic diseases. 3) In this population it is convenient to search systematically for this microorganism. 4) Isolates were mainly from respiratory samples (78%). 5) Favourable outcome depended on early diagnosis and adjusted treatment.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Morales, M. Santos, A. Gil, A. Navarro, M. Gobernado (Valencia, Spain). Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients. Eur Respir J 2008; 32: Suppl. 52, 1632

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Mycobacterium abscessus infection in lung transplant patients: review of our series
Source: Annual Congress 2007 - Complications and success in lung transplantation
Year: 2007


Identification of Mycobacterium tuberculosis (MTB)-infection in immunocompromised hosts
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005



Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012


Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Source: Eur Respir J 2015; 46: 1823-1826
Year: 2015


Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections
Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017
Year: 2017



Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013



A patient with cystic fibrosis and Mycobacterium abscessus infection
Source: International Congress 2018 – CC1 Lung transplantation
Year: 2018


Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia
Source: Eur Respir J 2014; 43: 178-184
Year: 2004



Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011


Accidental detection of mycobacterium tuberculosis infection in patients with various respiratory diseases
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008


Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008



Characterization of murine model of chronic M. abscessus respiratory infection.
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Mycobacterium tilburgii infection in an HIV-seropositive host
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Pneumonectomy in lung infections with Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001

LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016